Apogee Therapeutics (APGE) Short Interest Ratio & Short Volume → Read this before you buy AI stocks (From InvestorPlace) (Ad) Free APGE Stock Alerts $52.42 +2.11 (+4.19%) (As of 05/20/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Apogee Therapeutics Short Interest DataCurrent Short Interest4,840,000 sharesPrevious Short Interest4,550,000 sharesChange Vs. Previous Month+6.37%Dollar Volume Sold Short$243.45 millionShort Interest Ratio7.2 Days to CoverLast Record DateApril 30, 2024Outstanding Shares58,460,000 sharesFloat Size34,560,000 sharesShort Percent of Float14.00%Today's Trading Volume450,677 sharesAverage Trading Volume582,402 sharesToday's Volume Vs. Average77% Short Selling Apogee Therapeutics ? Sign up to receive the latest short interest report for Apogee Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAPGE Short Interest Over TimeAPGE Days to Cover Over TimeAPGE Percentage of Float Shorted Over Time Ad InvestorPlaceRead this before you buy AI stocksBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. Apogee Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,840,000 shares $243.45 million +6.4%14.0%7.2 $50.30 4/15/20244,550,000 shares $241.47 million -1.1%13.0%6.6 $53.07 3/31/20244,600,000 shares $305.67 million +50.8%13.1%6.8 $66.45 3/15/20243,050,000 shares $208.35 million -2.6%9.8%4.8 $68.31 2/29/20243,130,000 shares $108.99 million -5.2%14.6%6.1 $34.82 2/15/20243,300,000 shares $117.94 million -12.0%15.4%9.9 $35.74 1/31/20243,750,000 shares $125.63 million No Change17.6%11.4 $33.50 APGE Short Interest - Frequently Asked Questions What is Apogee Therapeutics' current short interest? Short interest is the volume of Apogee Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 4,840,000 shares of APGE short. 14.00% of Apogee Therapeutics' shares are currently sold short. Learn More on Apogee Therapeutics' current short interest. What is a good short interest ratio for Apogee Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APGE shares currently have a short interest ratio of 7.0. Learn More on Apogee Therapeutics's short interest ratio. Which institutional investors are shorting Apogee Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Apogee Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Apogee Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.00% of Apogee Therapeutics' floating shares are currently sold short. Is Apogee Therapeutics' short interest increasing or decreasing? Apogee Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 4,840,000 shares, an increase of 6.4% from the previous total of 4,550,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Apogee Therapeutics' float size? Apogee Therapeutics currently has issued a total of 58,460,000 shares. Some of Apogee Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Apogee Therapeutics currently has a public float of 34,560,000 shares. How does Apogee Therapeutics' short interest compare to its competitors? 14.00% of Apogee Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Apogee Therapeutics: Vericel Co. (9.22%), Recursion Pharmaceuticals, Inc. (24.98%), Kymera Therapeutics, Inc. (16.15%), ADMA Biologics, Inc. (3.82%), Sana Biotechnology, Inc. (20.85%), Novavax, Inc. (32.00%), Beam Therapeutics Inc. (17.03%), Immunocore Holdings plc (9.37%), Twist Bioscience Co. (20.49%), Fusion Pharmaceuticals Inc. (4.64%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Apogee Therapeutics stock? Short selling APGE is an investing strategy that aims to generate trading profit from Apogee Therapeutics as its price is falling. APGE shares are trading up $2.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Apogee Therapeutics? A short squeeze for Apogee Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of APGE, which in turn drives the price of the stock up even further. How often is Apogee Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APGE, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Vericel Short Interest Data Recursion Pharmaceuticals Short Interest Data Kymera Therapeutics Short Interest Data ADMA Biologics Short Interest Data Sana Biotechnology Short Interest Data Novavax Short Interest Data Beam Therapeutics Short Interest Data Immunocore Short Interest Data Twist Bioscience Short Interest Data Fusion Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APGE) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto for AIWeiss Ratings**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock Digest